Southwest Gas Q1 2026 slides: regulatory progress amid earnings miss

Southwest Gas reported Q1 2026 EPS of $1.91, missing the $2.04 consensus by 6.4%, while revenue of $585.1 million fell 15.4% short of expectations. Management reaffirmed full-year 2026 adjusted EPS guidance of $4.17 to $4.32 and long-term 12% to 14% annual EPS growth through 2030, supported by a $1.7 billion Great Basin pipeline expansion and new rate case filings seeking about $172 million in annual revenue increases. The stock fell 2.42% pre-market after the miss, but the company highlighted strong liquidity, a 4% dividend increase to $0.645 per share, and improving regulatory visibility.

Analysis

SWX is increasingly a regulated-duration asset with a visible earnings runway, but the market is still paying for execution optionality before the cash flow is fully de-risked. The key second-order effect is that the combination of lower parent-level debt and excess liquidity makes the equity story less about balance sheet repair and more about regulatory timing; that typically compresses near-term downside unless a rate case slips materially. In other words, the equity is now trading on the probability distribution of future allowed returns, not on current-quarter operating noise.

The biggest hidden lever is the Great Basin project’s open-season over-subscription, which signals that the real constraint is not demand but regulatory/capital execution. If the project stays on schedule, the company will likely graduate from a steady utility compounding story to a multi-year rate base acceleration story, and that should support multiple expansion versus slower-growth gas utilities. The flip side is that a large construction program creates a classic utility overhang: any delay, higher-than-modeled financing cost, or FERC/regulatory friction would hit both the growth narrative and the implied discount rate at the same time.

Near term, the most important catalyst is the California final decision because it shifts already-earned economics into reported results; that creates a cleaner EPS back-half setup over the next 1-2 quarters. Longer term, the 2026-27 rate cases matter more than management guidance because they determine how much of the planned capital base can be monetized without lag. The contrarian view is that the stock may be less expensive than headline growth suggests because investors are still underpricing the stability of utility cash flows relative to the capital intensity required to deliver them; however, at this valuation, any miss in the regulatory cadence can de-rate the name quickly.

For competitors, the likely loser is any regional gas utility with slower rate base growth and weaker project pipeline, because SWX now has a clearer path to above-peer organic growth if it executes. Bondholders are an indirect beneficiary if the company stays disciplined: the large cash position and moderate leverage reduce near-term refinancing risk, which should keep utility credit spreads tight and equity dilution limited.

Key Decisions for Investors

• Stay long SWX on a 3-6 month horizon into the California decision and Nevada rate-case milestones; the setup favors a gradual re-rating if reported earnings catch up to run-rate allowed returns. Risk/reward is attractive as long as the stock remains range-bound near recent highs without a regulatory miss.
• Buy SWX call spreads 6-12 months out to express upside from rate-case resolution and Great Basin de-risking while capping premium outlay. This is preferable to common stock if you want convexity without taking full valuation risk.
• Pair trade: long SWX / short a slower-growth regulated gas utility with weaker capex visibility over the next 12 months. The thesis is relative multiple expansion for the name with the clearest rate base acceleration and project optionality.
• Reduce exposure or hedge if California slips beyond the next quarter or if Nevada process timing starts to move right; those are the two events most likely to pressure near-term multiple support. A simple put-spread hedge into those dates should be sufficient rather than outright de-risking.
• Use any post-earnings weakness as an entry window only if the stock trades down on headline miss without guidance cuts; that would likely be an execution discount, not a thesis break. The asymmetric upside is in the 2027-2030 earnings power, not the next printed quarter.